Case Report | September 28, 2024
Etanercept induced erectile dysfunction
Ozge Sonmez, Serdal Ugurlu
Ozge Sonmez, Serdal Ugurlu
Reem Khalid Ali, Ebtesam Safi, Tibah Ahmad Al Abbasi, Salma AlRajaby
Leonard Ssebwami, Charles Balungi, Henry Kule, Carol Atino, Simon Byonanuwe
Arnetta Naomi Louise Lalisang, Patricia Rosalind Ismantara, Nathaniel Jason Zacharia, Indah Jamtani
Bader Basem Alrowaished, Elsayed Ali, Mohammed Saeed Alhejji, Mohammed Sami Albohassen, Ali Mohammed Aldandan
Frank Mulindwa, Sana Chaudhary, Jewel Estrella, Vivek Kandanati
Background: Mycobacterium abscessus (M. abscessus), a rapidly growing Mycobacterium (RGM) is an emergent cause of soft issue and musculoskeletal infections. Treatment is often complicated by commonly occurring intrinsic and acquired resistance to not only the classical anti-tuberculous agents but also to most currently available antibiotics. Case Presentation: We present a case of left thumb carpometacarpal (CMC) joint septic arthritis in a 66-year-old American Caucasian woman following an intra-articular steroid injection for osteoarthritis treatment. She did not improve on conventional empirical cellulitis treatment prompting culture and sensitivity assays. Mycobacterium abscessus Deoxyribonucleic acid was detected by real-time polymerase chain reaction (PCR) with additional cultures growing the same organism within a week. Samples were sent to the New York State Department of Health for a full culture and sensitivity profile which demonstrated extensive resistance to antibacterial agents including conventional anti-tuberculous agents. Conclusion: This case not only highlights the importance of having a high degree of suspicion for M. abscessus in joint and soft tissue infections not improving to commonly used empirical therapies even in low prevalent areas. It also underlines the importance of performing cultures and sensitivity given antibiotic combinations for most RGM infections should be sensitivity guided.
Rani Singh, Sharath Kandhi, Ashwini Kshirsagar, Terri-Ann Gizienski
Background: This case series highlights the role of Hologic Genius AI™ Detection solution in improving breast cancer detection rates. Through AI-driven technology, Genius AI Detection solution enhances the accuracy and efficiency of identifying suspicious breast lesions, leading to early diagnosis and intervention. By leveraging deep learning algorithms, Genius AI Detection solution provides actionable computer-aided detection (CAD) findings in identifying and aiding in the interpretation of potential abnormalities in breast tomosynthesis images. It also helps prioritize cases to potentially improve reading efficiency ultimately impacting breast imaging and patient care.
Case Presentation: We present three challenging cases from a routine screening population, wherein patients flagged as high-priority or suspicious for malignancy by Genius AI Detection solution were subsequently diagnosed with invasive ductal carcinoma (IDC), ductal carcinoma in situ (DCIS), and invasive lobular carcinoma that were all validated through biopsy and histopathological examination. We demonstrate the clinical utility of Hologic Genius AI Detection solution in detecting various types of breast cancers, including DCIS in a young patient with dense breast tissue and a family history of breast cancer, IDC in a patient with scattered fibroglandular densities and no family history, and invasive lobular carcinoma in a patient with similar breast density characteristics and no family history of breast cancer.
Conclusion: The cases exemplify how Hologic Genius AI Detection solution can potentially improve breast cancer detection in clinical practice.
,
Dear authors and visitors,
The European Journal of Medical Case Reports (EJMCR) is currently in the process of migrating to a new server. You may experience temporary site outages, broken links, or other technical issues. We kindly ask for your patience during this transition, and we will be back online as soon as possible.
If you had submitted a manuscript through our previous submission system, you can continue to check for updates by logging into the previous journal submission system: http://www.ejmanager.com/my/ejmcr/.
Reviewers who accepted to review via our previous journal system, may log in via following link:
https://www.ejmanager.com/reviewers/index.php?isl=login
Thank you for your understanding and continued support.
Background: Linezolid like many other systemic drugs can cause reversible sight threatening adverse reaction. A proper causality assessment tool can help decide discontinuing a drug when an adverse event is suspected.
Case presentation: We describe a case of progressive visual loss in a 28-year-old lady under long term linezolid for extensively drug resistant tuberculosis. A marked improvement in vision was seen on discontinuation of linezolid.
Conclusion: Knowledge of visual monitoring in patients under long term linezolid therapy among physicians and ophthalmologists is important, especially in developing countries where infectious disease is still a problem and use of antimicrobials is hardly monitored.
Read full article